Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James T. Parsons

Director at Oncolytics Biotech Inc (ONCY)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-16.3%
vs. S&P 500-28.0%
Beat the market0%
Paper profit on buys−$5K
Total bought / sold$10K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Mar 13SEC ONCYOncolytics Biotech Inc Buy 10,00041,849 held (+31%) $1.03 $10K -45.6%
  • Buy

    Director James T. Parsons bought $10K of ONCY at $1.03 — first open-market purchase in our records; raises the stake by 31%.